Guidance for Blood and Plasma Facilities

CDC is working with FDA, state and local health departments, and other HHS agencies to monitor COVID-19 and its potential impact on blood availability and blood safety. CDC and other HHS agencies are also continuing to work with the AABB Interorganizational Disaster Task Force to enhance preparednesspdf icon.

Source link

Leave a Reply